Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Propofol 500mg/50ml emulsion for infusion vials
1501010L0AAABAB
|
Propofol | Propofol | Anaesthesia | No data available |
|
Propofol 500mg/50ml inf pre-filled syringes
1501010L0AAAFAF
|
Propofol | Propofol | Anaesthesia | No data available |
|
Propofol-Lipuro 1% emulsion for infusion 100ml vials
1501010L0BCADAC
|
Propofol-Lipuro | Propofol | Anaesthesia | No data available |
|
Propofol-Lipuro 1% emulsion for infusion 50ml ampoules
1501010L0BCAAAH
|
Propofol-Lipuro | Propofol | Anaesthesia | No data available |
|
Propofol-Lipuro 1% emulsion for infusion 50ml vials
1501010L0BCABAB
|
Propofol-Lipuro | Propofol | Anaesthesia | No data available |
|
Propofol-Lipuro 1% emulsion for injection 20ml ampoules
1501010L0BCAEAA
|
Propofol-Lipuro | Propofol | Anaesthesia | No data available |
|
Propofol-Lipuro 2% emulsion for infusion 50ml vials
1501010L0BCACAD
|
Propofol-Lipuro | Propofol | Anaesthesia | No data available |
|
Propoven 1% emulsion for infusion 100ml vials
1501010L0BDAAAC
|
Propoven | Propofol | Anaesthesia | No data available |
|
Propoven 1% emulsion for infusion 50ml vials
1501010L0BDABAB
|
Propoven | Propofol | Anaesthesia | No data available |
|
Propoven 1% emulsion for injection 20ml ampoules
1501010L0BDADAA
|
Propoven | Propofol | Anaesthesia | No data available |
|
Propoven 2% emulsion for infusion 50ml vials
1501010L0BDACAD
|
Propoven | Propofol | Anaesthesia | No data available |
|
Rapydan 70mg/70mg medicated plasters
1502010Y0BBAAAA
|
Rapydan | Lidocaine and tetracaine | Anaesthesia | No data available |
|
Remifentanil 1mg powder for solution for injection vials
1501010Q0AAAAAA
|
Remifentanil hydrochloride | Remifentanil hydrochloride | Anaesthesia | No data available |
|
Remifentanil 2mg powder for solution for injection vials
1501010Q0AAABAB
|
Remifentanil hydrochloride | Remifentanil hydrochloride | Anaesthesia | No data available |
|
Remifentanil 5mg powder for solution for injection vials
1501010Q0AAACAC
|
Remifentanil hydrochloride | Remifentanil hydrochloride | Anaesthesia | No data available |
|
Robinul 200micrograms/1ml solution for injection ampoules
1501030G0BBAAAA
|
Robinul (Parenteral) | Glycopyrronium bromide | Anaesthesia | No data available |
|
Robinul 600micrograms/3ml solution for injection ampoules
1501030G0BBABAB
|
Robinul (Parenteral) | Glycopyrronium bromide | Anaesthesia | No data available |
|
Robinul-Neostigmine solution for injection 1ml ampoules
1501060N0BBAAAA
|
Robinul-Neostig | Neostigmine metilsulfate | Anaesthesia | No data available |
|
Rocuronium bromide 100mg/10ml inj ampoules
1501050X0AAAFAF
|
Rocuronium bromide | Rocuronium bromide | Anaesthesia | No data available |
|
Rocuronium bromide 100mg/10ml solution for injection vials
1501050X0AAABAB
|
Rocuronium bromide | Rocuronium bromide | Anaesthesia | No data available |
|
Rocuronium bromide 50mg/5ml solution for injection ampoules
1501050X0AAAEAE
|
Rocuronium bromide | Rocuronium bromide | Anaesthesia | No data available |
|
Rocuronium bromide 50mg/5ml solution for injection vials
1501050X0AAACAC
|
Rocuronium bromide | Rocuronium bromide | Anaesthesia | No data available |
|
Ropivacaine 100mg/10ml solution for injection ampoules
1502010R0AAAEAE
|
Ropivacaine hydrochloride | Ropivacaine hydrochloride | Anaesthesia | No data available |
|
Ropivacaine 200mg/100ml infusion bags
1502010R0AAAFAF
|
Ropivacaine hydrochloride | Ropivacaine hydrochloride | Anaesthesia | No data available |
|
Ropivacaine 20mg/10ml solution for injection ampoules
1502010R0AAAAAA
|
Ropivacaine hydrochloride | Ropivacaine hydrochloride | Anaesthesia | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.